Neglecting lipid-lowering therapy is a common phenomenon. The reasons why patients didn't accept or didn't completely accept lipid-lowering therapy include: doctors didn't know enough about the clinical benefits brought by lipid-lowering therapy, they didn't know the blood lipid standard and the ideal target level when starting drug lipid-lowering therapy, they were too skeptical about the possible adverse reactions of lipid-lowering therapy, they were too optimistic about the effect of diet therapy, and their cost-benefit evaluation was improper.
Without systematic engineering support, the treatment of clinicians will be greatly reduced. Everything will be fine when the doctor builds the bridge, and no one cares whether the patient will take medicine in the future. Patients also believe that one operation can cure them. They don't know what medicine to take, how long to take it and how to maintain a healthy lifestyle. In China, for a long time, some patients with myocardial infarction, angina pectoris or coronary heart disease died outside the hospital, a small number died in the hospital, and a large number died of recurrence without systematic management after discharge.